Cargando…

Glucagon-like peptide-1 and the exenatide analogue AC3174 improve cardiac function, cardiac remodeling, and survival in rats with chronic heart failure

BACKGROUND: Accumulating evidence suggests glucagon-like peptide-1 (GLP-1) exerts cardioprotective effects in animal models of myocardial infarction (MI). We hypothesized that chronic treatment with GLP-1 or the exenatide analog AC3174 would improve cardiac function, cardiac remodeling, insulin sens...

Descripción completa

Detalles Bibliográficos
Autores principales:	Liu, Que, Anderson, Christen, Broyde, Anatoly, Polizzi, Clara, Fernandez, Rayne, Baron, Alain, Parkes, David G
Formato:	Texto
Lenguaje:	English
Publicado:	BioMed Central 2010
Materias:	Original Investigation
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2996354/ https://www.ncbi.nlm.nih.gov/pubmed/21080957 http://dx.doi.org/10.1186/1475-2840-9-76

Ejemplares similares

The exenatide analogue AC3174 attenuates hypertension, insulin resistance, and renal dysfunction in Dahl salt-sensitive rats
por: Liu, Que, et al.
Publicado: (2010)

Effect of the Glucagon‐like Peptide‐1 Analogue Exenatide Extended Release in Cats with Newly Diagnosed Diabetes Mellitus
por: Riederer, A., et al.
Publicado: (2016)

Glycemic variability in newly diagnosed diabetic cats treated with the glucagon‐like peptide‐1 analogue exenatide extended release
por: Krämer, Anna L., et al.
Publicado: (2020)

Combined antidiabetic benefits of exenatide and dapagliflozin in diabetic mice
por: Tatarkiewicz, K, et al.
Publicado: (2014)

The association of the treatment with glucagon-like peptide-1 receptor agonist exenatide or insulin with cardiovascular outcomes in patients with type 2 diabetes: a retrospective observational study
por: Paul, Sanjoy K, et al.
Publicado: (2015)

Effects of exenatide on cardiac function, perfusion, and energetics in type 2 diabetic patients with cardiomyopathy: a randomized controlled trial against insulin glargine
por: Chen, Weena J. Y., et al.
Publicado: (2017)

Exenatide at mealtimes in type 1 diabetes—no MAG1C with exenatide, or with other glucagon-like peptide-1 receptor agonists
por: Doggrell, Sheila A.
Publicado: (2020)

Long-term changes in cardiovascular risk markers during administration of exenatide twice daily or glimepiride: results from the European exenatide study
por: Simó, Rafael, et al.
Publicado: (2015)

Targeting the glucagon receptor improves cardiac function and enhances insulin sensitivity following a myocardial infarction
por: Karwi, Qutuba G., et al.
Publicado: (2019)

The adipokine fatty-acid binding protein 4 and cardiac remodeling
por: von Jeinsen, Beatrice, et al.
Publicado: (2020)

Early dysregulation of cardiac-specific microRNA-208a is linked to maladaptive cardiac remodelling in diabetic myocardium
por: Rawal, Shruti, et al.
Publicado: (2019)

Data on the genome analysis of the wood-rotting fungus Steccherinum ochraceum LE-BIN 3174
por: Moiseenko, Konstantin, et al.
Publicado: (2020)

Influence of apocynin on cardiac remodeling in rats with streptozotocin-induced diabetes mellitus
por: Gimenes, R., et al.
Publicado: (2018)

Glucagon and exenatide improve contractile recovery following ischaemia/reperfusion in the isolated perfused rat heart
por: Lindsay, Ross T., et al.
Publicado: (2023)

Effects of exenatide on postprandial vascular endothelial dysfunction in type 2 diabetes mellitus
por: Torimoto, Keiichi, et al.
Publicado: (2015)

Apocynin influence on oxidative stress and cardiac remodeling of spontaneously hypertensive rats with diabetes mellitus
por: Rosa, C. M., et al.
Publicado: (2016)

Interleukin-6 predicts inflammation-induced increase of Glucagon-like peptide-1 in humans in response to cardiac surgery with association to parameters of glucose metabolism
por: Lebherz, Corinna, et al.
Publicado: (2016)

Effects of Ginkgo leaf tablets on the pharmacokinetics of losartan and its metabolite EXP3174 in rats and its mechanism
por: Dong, Baiping, et al.
Publicado: (2018)

Haptoglobin genotype is a determinant of survival and cardiac remodeling after myocardial infarction in diabetic mice
por: Asaf, Roy, et al.
Publicado: (2009)

Histone deacetylase (HDAC) inhibition improves myocardial function and prevents cardiac remodeling in diabetic mice
por: Chen, Youfang, et al.
Publicado: (2015)

Successful metabolic adaptations leading to the prevention of high fat diet-induced murine cardiac remodeling
por: Roberts, Nathan W., et al.
Publicado: (2015)

Longitudinal cardiac remodeling in collegiate American football players as assessed by echocardiography during their collegiate career
por: Hamburger, Robert F., et al.
Publicado: (2023)

Exenatide Protects Against Cardiac Dysfunction by Attenuating Oxidative Stress in the Diabetic Mouse Heart
por: Ding, Wei, et al.
Publicado: (2019)

Exenatide induces aortic vasodilation increasing hydrogen sulphide, carbon monoxide and nitric oxide production
por: Sélley, Eszter, et al.
Publicado: (2014)

Glucagon-like peptide-1 enhances cardiac L-type Ca(2+ )currents via activation of the cAMP-dependent protein kinase A pathway
por: Xiao, Yong-Fu, et al.
Publicado: (2011)

Glucagon-like peptide-1 analogues: An overview
por: Gupta, Vishal
Publicado: (2013)

Effects of Exenatide vs. Metformin on endothelial function in obese patients with pre-diabetes: a randomized trial
por: Kelly, Aaron S, et al.
Publicado: (2012)

Exenatide can inhibit calcification of human VSMCs through the NF-kappaB/RANKL signaling pathway
por: Zhan, Jun-Kun, et al.
Publicado: (2014)

Efficacy of liraglutide, a glucagon-like peptide-1 (GLP-1) analogue, on body weight, eating behavior, and glycemic control, in Japanese obese type 2 diabetes
por: Fujishima, Yuya, et al.
Publicado: (2012)

Metabolically-inactive glucagon-like peptide-1(9–36)amide confers selective protective actions against post-myocardial infarction remodelling
por: Robinson, Emma, et al.
Publicado: (2016)

miR-3174 Contributes to Apoptosis and Autophagic Cell Death Defects in Gastric Cancer Cells by Targeting ARHGAP10
por: Li, Bowen, et al.
Publicado: (2017)

miR-3174 Is a New Tumor Suppressor MicroRNA That Inhibits Several Tumor-Promoting Genes in Glioblastoma
por: Hanif, Farina, et al.
Publicado: (2023)

Metabolomic Profile, Plasmatic Levels of Losartan and EXP3174, Blood Pressure Control in Hypertensive Patients and Their Correlation with COVID-19
por: Queiroz, Kamila A., et al.
Publicado: (2023)

Effect of the glucagon-like peptide-1 analogue liraglutide on coronary microvascular function in patients with type 2 diabetes – a randomized, single-blinded, cross-over pilot study
por: Faber, Rebekka, et al.
Publicado: (2015)

Cardiovascular safety of exenatide BID: an integrated analysis from controlled clinical trials in participants with type 2 diabetes
por: Ratner, Robert, et al.
Publicado: (2011)

Diabetes mellitus activates fetal gene program and intensifies cardiac remodeling and oxidative stress in aged spontaneously hypertensive rats
por: Rosa, Camila Moreno, et al.
Publicado: (2013)

The microRNA miR-3174 Suppresses the Expression of ADAM15 and Inhibits the Proliferation of Patient-Derived Bladder Cancer Cells
por: Yu, Chunhu, et al.
Publicado: (2020)

Long-Acting GLP-1 Receptor Agonist Exenatide Influence on the Autonomic Cardiac Sympatho-Vagal Balance
por: Cacciatori, Vittorio, et al.
Publicado: (2017)

Effects of 6-month treatment with the glucagon like peptide-1 analogue liraglutide on arterial stiffness, left ventricular myocardial deformation and oxidative stress in subjects with newly diagnosed type 2 diabetes
por: Lambadiari, Vaia, et al.
Publicado: (2018)

Evaluation of the cost effectiveness of exenatide versus insulin glargine in patients with sub-optimally controlled Type 2 diabetes in the United Kingdom
por: Woehl, Anette, et al.
Publicado: (2008)

Cannot write session to /tmp/vufind_sessions/sess_gfqdqhcp6e0nqjchdh31hernij